Trospium Chloride Patent Expiration
Trospium Chloride is Used for treating bladder dysfunction. It was first introduced by Allergan Inc
Trospium Chloride Patents
Given below is the list of patents protecting Trospium Chloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sanctura Xr | US7410978 | Once daily dosage forms of trospium | Feb 01, 2025 | Allergan |
| Sanctura Xr | US7759359 | Method of treating bladder dysfunction with once-a-day trospium salt formulation |
Nov 04, 2024
(Expired) | Allergan |
| Sanctura Xr | US7763635 | Once daily dosage forms of trospium |
Nov 04, 2024
(Expired) | Allergan |
| Sanctura Xr | US7781448 | Once daily dosage forms of trospium |
Nov 04, 2024
(Expired) | Allergan |
| Sanctura Xr | US7781449 | Trospium chloride treatment method |
Nov 04, 2024
(Expired) | Allergan |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Trospium Chloride's patents.
Latest Legal Activities on Trospium Chloride's Patents
Given below is the list recent legal activities going on the following patents of Trospium Chloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical | 01 Oct, 2018 | US7781449(Litigated) |
| Expire Patent Critical | 01 Oct, 2018 | US7781448(Litigated) |
| Expire Patent Critical | 03 Sep, 2018 | US7763635(Litigated) |
| Expire Patent Critical | 27 Aug, 2018 | US7759359(Litigated) |
| Maintenance Fee Reminder Mailed Critical | 09 Apr, 2018 | US7781449(Litigated) |
| Maintenance Fee Reminder Mailed Critical | 09 Apr, 2018 | US7781448(Litigated) |
| Maintenance Fee Reminder Mailed Critical | 12 Mar, 2018 | US7763635(Litigated) |
| Maintenance Fee Reminder Mailed Critical | 05 Mar, 2018 | US7759359(Litigated) |
| Expire Patent Critical | 09 Sep, 2016 | US7410978(Litigated) |
| Change in Power of Attorney (May Include Associate POA) Critical | 27 Apr, 2015 | US7759359(Litigated) |
Trospium Chloride's Family Patents
Explore Our Curated Drug Screens
Trospium Chloride Generic API Manufacturers
Several generic applications have been filed for Trospium Chloride. The first generic version for Trospium Chloride was by Glenmark Pharmaceuticals Ltd and was approved on Aug 13, 2010. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Jun 18, 2024.
Given below is the list of companies who have filed for Trospium Chloride generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG
(reference standard) | capsule, extended release | Prescription | ORAL | AB | Oct 12, 2012 |
2. APOTEX
Apotex Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Dec 6, 2011 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Feb 16, 2022 |
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 13, 2010 |
5. GRANULES
Granules Pharmaceuticals Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | capsule, extended release | Prescription | ORAL | AB | Apr 23, 2020 |
Manufacturing Plant Locations New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
| India |
| |||||||||||
6. HERITAGE PHARMS INC
Heritage Pharmaceuticals Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Heritage Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Aug 30, 2016 |
7. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Aug 23, 2016 |
8. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Jun 18, 2024 |
9. PADAGIS US
Padagis Us Llc has filed for 2 different strengths of generic version for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Nov 17, 2010 |
| 60MG | capsule, extended release | Prescription | ORAL | AB | May 24, 2013 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
10. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 29, 2015 |
11. UTOPIC PHARMS
Utopic Pharmaceuticals Inc has filed for 1 generic for Trospium Chloride. Given below are the details of the strengths of this generic introduced by Utopic Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | capsule, extended release | Prescription | ORAL | AB | Apr 30, 2021 |